Cat. No. | Product name | CAS No. |
DC4239 |
Flupirtine maleate
Flupirtine maleateis a non-opioid, centrally acting analgesia, muscle relaxation and neuroprotection. Currently under a clinical trial (recruiting phase) as a treatment for Multiple Sclerosis and has been used as an analgesic. |
75507-68-5 |
DC9859 |
GAL-021
Featured
GAL-021 is a new intravenous BKCa-channel blocker. |
1380341-99-0 |
DC10078 |
ICA 069673
Featured
ICA 069673 is a potassium channel opener with selective action for KCNQ2 and KCNQ3 (EC50=0.69 μM). No meeasurable activity was displayed over a variety of cardiac ion channels. |
582323-16-8 |
DC11031 |
IK1 inhibitor PA-6
IK1 inhibitor PA-6 is an efficient, specific inhibitor of inward rectifier current (IK1), blocks KIR2.x currents of human and mouse with IC50 of 12-15 nM. |
500715-03-7 |
DCAPI1506 |
Mitiglinide Calcium
Inhibitor of ATP-sensitive K+ channel activity in MIN 6 cells. Has also been shown to bind sulfonylurea receptors as well. |
145525-41-3 |
DC8850 |
ML-213(CID-3111211)
Featured
ML-213 (CID-3111211) is a selective KV7.2 (KCNQ2) and KV7.4 (KCNQ4) channel opener (EC50 values are 230 and 510 nM for KV7.2 and KV7.4 respectively). |
489402-47-3 |
DC7798 |
ML-277
Featured
ML-277 is a potent activator of KCNQ1 ( K(v)7.1) channels (EC50 = 260 nM). |
1401242-74-7 |
DC10849 |
ML297 (VU0456810)
Featured
ML297 (VU0456810) is the First Potent and Selective Activator of the GIRK Potassium Channel, Displays Antiepileptic Properties in Mice. |
1443246-62-5 |
DC10743 |
ml335
Featured
ML335 is a selective activator of both TREK-1 and TREK-2. |
825658-06-8 |
DC7797 |
ML365
Featured
ML365 is a novel selective small molecule inhibitor of TASK1(KCNK3) with IC50 of 4 nM(thallium influx fluorescent assay) and 16 nM(automated electrophysiology assay). |
947914-18-3 |
DC10557 |
ML402
Featured
ML402 is a selective TREK-1 activator. |
298684-44-3 |
DC8969 |
Nicorandil
Nicorandil is potassium channel activator. |
65141-46-0 |
DC9131 |
Nimodipine
Nimodipine(Nimotop) is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity.Nimodipine decreases intracellular free Ca2+,Beclin-1 and autophagy. |
66085-59-4 |
DC8789 |
NS 11021
Featured
NS 11021 is an activator of large-conductance Ca2+-activated potassium channels (BKCa, KCa1.1). |
956014-19-0 |
DC9734 |
NS-1619
Featured
NS-1619 is a selective MaxiKα (large conductance calcium activated potassium channel) activator. |
153587-01-0 |
DC6910 |
NS-1643
Featured
NS1643 is a potent human ether-a-go-go related gene (hERG) KV11.1 channel activator (EC50 = 10.5 μM). |
448895-37-2 |
DC7833 |
NS309
Featured
NS309 is a positive modulator of small- and intermediate- conductance Ca2+-activated K+ channels (KCa2 and KCa3.1 channels); increases Ca2+ sensitivity. Displays no activity at BK channels. |
18711-16-5 |
DC8269 |
NS6180
Featured
NS6180 is a novel inhibitor of the intermediate-conductance Ca2+-activated K+ channel (KCa3.1) |
353262-04-1 |
DC12096 |
Pinacidil monohydrate (Pinacidil hydrate)
Featured
Pinacidil monohydrate, an antihypertensive drug, is a potassium channel activator. |
85371-64-8 |
DC8807 |
Retigabine dihydrochloride
Featured
Retigabine 2Hcl (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity. |
150812-13-8 |
DC8105 |
RPR-260243
RPR260243 was the first reported hERG channel activator. |
668463-35-2 |
DC9600 |
Senicapoc
Featured
Senicapoc(ICA17043) is a potent and selective Gardos channel blocker; blocked Ca(2+)-induced rubidium flux from human RBCs/ inhibited RBC dehydration with IC50s of 11 nM/30 nM, respectively. IC50 value: 11/30 nM [1] Target: Gardos channel in vitro: I |
289656-45-7 |